Form 4 for RNTX Rein Therapeutics, Inc.
Accepted 2023-11-21 00:00:00 ET · period of report 2023-11-20 · accession 0000950170-23-065545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-21 | 2023-11-20 | RNTX | WINDSOR JAMES BRIAN | Pres, COO | P - Purchase | $1.97 | +5,076 | 5,122 | +11,035% | +$10,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-20 | P | A | 5,076 | $1.97 | 5,122 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.965 - $1.9699. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |